Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Astellas Gene Therapies financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

CreditSafe Score

Score changed on Feb 21, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2016FY, 2017FY, 2018
General and administrative expense11.3M17.3M30.0M
Operating expense total60.0M93.2M134.4M
Investment income767.0K6.0M
Interest income472.0K
Pre tax profit(59.7M)(92.5M)(128.8M)
Income tax expense(2.2M)
Net Income(59.7M)(90.2M)(128.8M)

Footer menu